X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (15) 15
humans (13) 13
female (10) 10
male (10) 10
melanoma (9) 9
flow cytometry (8) 8
survival (8) 8
t cells (8) 8
aged (7) 7
middle aged (7) 7
biomarkers (6) 6
cancer (6) 6
life sciences (6) 6
lymphocytes (6) 6
lymphocytes t (6) 6
melanoma - immunology (6) 6
oncology (6) 6
γδ t-cells (6) 6
[ sdv.can ] life sciences [q-bio]/cancer (5) 5
biomarker (5) 5
immunology (5) 5
immunotherapy (5) 5
ipilimumab (5) 5
t cell receptors (5) 5
adult (4) 4
article (4) 4
ctla-4 blockade (4) 4
cytomegalovirus (4) 4
differentiation phenotype (4) 4
human ageing (4) 4
melanoma - drug therapy (4) 4
melanoma - mortality (4) 4
melanoma - pathology (4) 4
metastasis (4) 4
metastatic melanoma (4) 4
patients (4) 4
prognosis (4) 4
research (4) 4
age (3) 3
aged, 80 and over (3) 3
aging (3) 3
antibodies, monoclonal - therapeutic use (3) 3
antigens (3) 3
bioindicators (3) 3
biomarkers, tumor - blood (3) 3
blood (3) 3
care and treatment (3) 3
cell biology (3) 3
clinical trials (3) 3
cmv (3) 3
cytomegalovirus infections (3) 3
cytometry (3) 3
kaplan-meier estimate (3) 3
ny-eso-1 (3) 3
pd-1 protein (3) 3
pembrolizumab (3) 3
peripheral blood (3) 3
skin neoplasms - drug therapy (3) 3
skin neoplasms - immunology (3) 3
skin neoplasms - pathology (3) 3
suppressor-cells (3) 3
t-cells (3) 3
t-lymphocyte subsets - immunology (3) 3
activation (2) 2
aging - immunology (2) 2
analysis (2) 2
antibodies (2) 2
antineoplastic agents - therapeutic use (2) 2
antineoplastic agents, immunological - therapeutic use (2) 2
b-lymphocytes - immunology (2) 2
biomarkers, tumor - immunology (2) 2
cancer therapies (2) 2
cd4 antigen (2) 2
cd4-positive t-lymphocytes - immunology (2) 2
cd8 antigen (2) 2
cell survival (2) 2
cytotoxicity (2) 2
experience (2) 2
flow cytometry - methods (2) 2
gamma delta t-cells (2) 2
genotype & phenotype (2) 2
geriatrics & gerontology (2) 2
geriatrics/gerontology (2) 2
hematology, oncology and palliative medicine (2) 2
immunoglobulins (2) 2
immunologic memory (2) 2
immunological memory (2) 2
immunosenescence (2) 2
immunotherapy - methods (2) 2
infection (2) 2
infections (2) 2
ipilimumab - therapeutic use (2) 2
leukocytes (2) 2
lymphocyte count (2) 2
lymphocytes b (2) 2
malignant melanoma (2) 2
medical research (2) 2
memory (2) 2
memory cells (2) 2
mortality (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet, ISSN 0140-6736, 10/2017, Volume 390, Issue 10105, pp. 1816 - 1817
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/S0140-6736(17)31816-0 Byline: Kilian Wistuba-Hamprecht (a), Graham... 
MEDICINE, GENERAL & INTERNAL | PEMBROLIZUMAB | NIVOLUMAB | IPILIMUMAB | Melanoma | Survival analysis | Immunoglobulins | Biomarkers | Metastasis | Patients | Cancer therapies
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 06/2016, Volume 22, Issue 12, pp. 2908 - 2918
Journal Article
International Journal of Cancer, ISSN 0020-7136, 02/2016, Volume 138, Issue 3, pp. 698 - 704
Human T cells carrying γδ T‐cell receptors (TCRs) represent a minor population relative to those with αβ TCRs. There has been much interest recently in the... 
malignant melanoma | γδ T‐cells | biomarker | survival | γδ T-cells | Phenotype | Prognosis | Receptors, Antigen, T-Cell, gamma-delta - analysis | Melanoma - immunology | Humans | Middle Aged | Receptors, Antigen, T-Cell, alpha-beta - analysis | Female | Immunologic Memory | Male | Melanoma - mortality | Index Medicus
Journal Article
AGE, ISSN 0161-9152, 12/2015, Volume 37, Issue 6, p. 1
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 12/2018, Volume 67, Issue 12, pp. 1845 - 1851
Increasing numbers of trials employing anti-PD-1 immunotherapy emphasize the requirement for predictive biomarkers of clinical response. Many studies examine... 
Flow cytometry | Pembrolizumab | Checkpoint blockade | Immunomonitoring | Nivolumab | SURVIVAL | NY-ESO-1 | SAFETY | PERIPHERAL-BLOOD | IMMUNOLOGY | ONCOLOGY | CIRCULATING CD4(+) | BLOCKADE | MELAN-A | LYMPHOCYTES | Viral antibodies | Antibodies | T cells | Immunotherapy | Immunoglobulins | PD-1 protein | Clinical trials | T cell receptors | Antagonists | Lymphocytes T | Cell surface | Cytometry | Cell activation | Stains | Index Medicus
Journal Article
Journal Article
Journal Article
Vaccine, ISSN 0264-410X, 08/2017, Volume 35, Issue 34, pp. 4330 - 4338
As age increases, immune responses and consequently protection following vaccination to seasonal influenza is commonly believed to decrease. Possible drivers... 
Cytomegalovirus | Adjuvant | Vaccine | regulatory T-cells | Influenza | Fluad | MEDICINE, RESEARCH & EXPERIMENTAL | POPULATION | CD4 T-CELLS | IMMUNOLOGY | CMV-INFECTION | B-CELLS | RESPONSES | IMMUNOGENICITY | MEMORY | Fluad (R) | AGE | HISTORY | Influenza Vaccines - administration & dosage | T-Lymphocytes, Regulatory - classification | B-Lymphocytes - classification | Adjuvants, Immunologic | Lymphocyte Activation | Humans | Vaccination | Immunophenotyping | Male | Cytomegalovirus Infections - immunology | CD4-Positive T-Lymphocytes - classification | Antibodies, Viral - blood | T-Lymphocytes, Regulatory - immunology | CD4-Positive T-Lymphocytes - immunology | B-Lymphocytes - immunology | Influenza Vaccines - immunology | Aged, 80 and over | Female | Immunosenescence | Influenza, Human - virology | Aged | Seasons | Influenza, Human - prevention & control | Influenza, Human - immunology | Influenza vaccines | Antigens | Cytomegalovirus infections | T cells | Elderly people | Laboratories | Clinical trials | Infections | Lymphocytes T | Vaccines | Older people | Peripheral blood | Age | Immunological memory | Memory cells | Myeloid cells | Immune response | Blood & organ donations | CD4 antigen | Immune systems | Lymphocytes B | Swine flu | Phenotyping | Biomarkers | Adults | Elderly | Viral infections | Geriatrics | Index Medicus
Journal Article
Cancer Immunology, Immunotherapy, ISSN 0340-7004, 4/2017, Volume 66, Issue 4, pp. 441 - 449
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2017, Volume 73, pp. 61 - 70
Abstract The role of the assessment of peripheral T-cell phenotypes in predicting overall survival (OS) after ipilimumab treatment is unclear. Here, we... 
Hematology, Oncology and Palliative Medicine | Biomarker | Effector memory cells | Prognosis | Ipilimumab | Melanoma | NY-ESO-1 | CTLA-4 BLOCKADE | PHENOTYPIC CHARACTERIZATION | ACTIVATION | IMPROVED SURVIVAL | METASTATIC MELANOMA | ONCOLOGY | CLINICAL-RESPONSE | TUMOR-IMMUNOTHERAPY | LYMPHOCYTES | BLOOD | Skin Neoplasms - drug therapy | Humans | Middle Aged | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Flow Cytometry | Antigens, Neoplasm - metabolism | Biomarkers, Tumor - metabolism | CD8-Positive T-Lymphocytes - metabolism | Adult | Female | Melanoma - metabolism | Skin Neoplasms - pathology | Skin Neoplasms - immunology | CD4-Positive T-Lymphocytes - metabolism | Kaplan-Meier Estimate | Programmed Cell Death 1 Receptor - metabolism | Melanoma - pathology | Skin Neoplasms - metabolism | Melanoma - immunology | Melanoma - drug therapy | Immunologic Memory | Aged | Care and treatment | T cells | Patient outcomes | Memory (Computers) | Analysis | Flow cytometry | Memory cells | Immunological memory | Cell survival | PD-1 protein | CD8 antigen | Effector cells | Leukocytes (mononuclear) | T cell receptors | Lymphocytes T | Patients | Cytometry | Electromagnetic interference | Correlation analysis | Response rates | Biomarkers | Bioindicators | Index Medicus | Life Sciences | Cancer | melanoma | biomarker | effector memory cells | prognosis | ipilimumab
Journal Article
Journal Article
International Journal of Cancer. Journal International du Cancer, ISSN 0020-7136, 02/2016, Volume 138, Issue 3, p. 698
  Human T cells carrying [gamma][delta] T-cell receptors (TCRs) represent a minor population relative to those with [alpha][beta] TCRs. There has been much... 
Genotype & phenotype | Medical prognosis | Melanoma | Biomarkers | T cell receptors | Metastasis
Journal Article
European Journal of Cancer, ISSN 0959-8049, 09/2016, Volume 64, pp. 116 - 126
Human γδ T-cells possess regulatory and cytotoxic capabilities, and could potentially influence the efficacy of immunotherapies. We analysed the frequencies of... 
Life Sciences | Cancer
Journal Article